High-intensity focused ultrasound for prostate cancer

3 Other NICE recommendations on high-intensity focused ultrasound for prostate cancer

Further recommendations have been made as part of the clinical guideline on prostate cancer published in February 2008, as follows:

High intensity focused ultrasound (HIFU) and cryotherapy are not recommended for men with localised prostate cancer other than in the context of controlled clinical trials comparing their use with established interventions.

Clinical and cost-effectiveness evidence was reviewed in the development of this guideline which has led to this more specific recommendation. More information is available in NICE's guideline on prostate cancer diagnosis and management. The IP guidance on high-intensity focused ultrasound for prostate cancer remains current, and should be read in conjunction with the clinical guideline.